1 / 6

A story of serendipity & Innovation

TACRINE (Cognex). A story of serendipity & Innovation. History of Tacrine, The FDA, and Alzheimer’s Disease. Begins at the dawn of the 20 th century. Dr. Summers becomes involved in 1976 with research on delirium.

gita
Download Presentation

A story of serendipity & Innovation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. TACRINE (Cognex) A story of serendipity & Innovation

  2. History of Tacrine, The FDA, and Alzheimer’s Disease • Begins at the dawn of the 20th century. • Dr. Summers becomes involved in 1976 with research on delirium. • In 1986 a UCLA team lead by Dr. Summers publishes a treatment of Alzheimer’s Disease for one year with Tacrine.

  3. Rules of Invention • Wrong Place • Wrong Industry • Wrong Time • Wrong Reasons

  4. Dr. Summers was • In private psychiatric practice (not at University or in neurology) • Doing self-funded research (no grants) • Received substantial publicity at a time that a major charity was promoting via President Regan’s administration that there was “No treatment” • Wrote a patent application so that there would be commercial interest and he could get further funding of his research.

  5. In Time Dr. Summers learns • Control your destiny • Speak out when you are right • There will be support • Sometimes and invention needs a champion. • Become an activist

  6. Tacrine became availableto the American public on September 30, 1993 as the first treatment for Alzheimer’s disease.

More Related